Pennsylvania’s medical marijuana program hobbled by lack of products to sell |

Pennsylvania’s medical marijuana program hobbled by lack of products to sell

Associated Press
Jars of medical marijuana on display on the counter of Western Caregivers Medical marijuana dispensary in Los Angeles.

PHILADELPHIA — Too much demand. Not enough supply.

Less than two weeks after it was launched, Pennsylvania’s medical marijuana program is a victim of its own success.

The two open marijuana dispensaries in the Philadelphia region reported Friday that they had sold out of most medicines and might not be restocked until after March 15.

“We have no inventory,” said Chris Visco, co-owner of the TerraVida Holistic Center in Sellersville, Bucks County. “We took a shipment on Wednesday. On Thursday, we had the biggest sales day we’ve ever had. By this morning, all we had left were a handful of disposable vape pens,” a type of electronic cigarette loaded with hashish oil.

Supplies were so limited at the Keystone Shop in Devon that the owners decided Thursday to close it.

“We’re looking at resuming sales the third week in March,” said Skip Shuda, Keystone Shop’s chief operating officer. “It’s frustrating for us, and it’s frustrating for a lot of patients who were looking for medicine.”

Several factors caused the drought. Chiefly, only one of Pennsylvania’s 12 licensed marijuana wholesalers, Cresco Yeltrah, is shipping to retailers. Two additional growers aren’t expected to have their crops harvested and processed into medicines until late March.

Visco said TerraVida was overwhelmed by the number of patients.

“I had projected 60 people initially for the entire month,” Visco said. “We had over 600 patients in our first eight days.”

TerraVida will remain open with modified hours for patient consultations and pre-orders, Visco said.

“Pennsylvania’s market is much larger than anybody anticipated,” Visco said. “No one could have projected it.”

In Bethlehem, Keystone Canna Remedies was down to a small number of cartridges filled with indica oil and some concentrates. Owner Victor Guadagnino said the shop was limiting sales to two cartridges per customer and would remain open to provide patient consultations.

“We’re going through some growing pains,” Guadagnino said. “But as other providers come on line, I don’t think we’ll see this issue again.”

April Hutcheson, a Department of Health spokeswoman, said two more dispensaries were scheduled to open in the next week in Southeastern Pennsylvania: Ilera Healthcare in Plymouth Meeting and Cure Pennsylvania in Phoenixville. Ilera could not be reached for comment. A spokesman for Cure said the Phoenixville dispensary was on schedule to open April 13.

“We encourage patients to call the dispensaries to find out if they have what they need and to set up a consultation,” Hutcheson said.

When the first phase of Pennsylvania’s medical marijuana program is running at capacity, a dozen grower-processors will service a total of 51 dispensaries.

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.